Phase 1 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have provided signed consent to participate
- People aged 18 years or older but under 65 years
- People with chronic kidney failure who are scheduled to receive a kidney transplant
- People with a body mass index (BMI) between 18 and 30 (a standard measure of body weight relative to height)
- People who weigh at least 50 kg (for males) or at least 45 kg (for females)
- People whose overall physical health status is classified by a doctor as ASA III or IV — meaning they have a serious ongoing medical condition (confirm with trial site)
Who may not be able to join:
- People who have liver disease, a psychiatric condition, or a neurological disorder
- People who have a blood clotting disorder
- People who have heart failure
- People who have respiratory (breathing) failure
- People who use sedatives or antidepressants on a long-term basis
- People who are pregnant or breastfeeding
- People who are unable to communicate or cooperate with trial requirements
- People who have taken part in another drug or medical device trial within the past 3 months
- People who test positive for hepatitis B
- People who test positive for hepatitis C
- People who test positive for HIV
- People who test positive for syphilis
- People who have taken certain medications that affect liver enzymes within the past 30 days (confirm with trial site for the specific list)
- People with a known allergic or sensitivity reaction to two or more substances
- People who have consumed more than 14 units of alcohol per week at any point in the 6 months prior to the trial
- People with a history of drug abuse within the past 3 months
- People who have had a major infection or serious physical injury within the past month
- People who have had gastrointestinal (digestive tract) surgery that could affect how the body absorbs medication within the past month
- People who have received a vaccine within the past month, or who plan to receive one during the study period
- People who have lost or donated more than 400 mL of blood within the past 3 months
- People who have received a blood transfusion within the past month
- People whose blood clotting test results fall outside acceptable ranges (confirm with trial site)
- People with a history of significant bleeding episodes within the past 3 months
- People who are currently taking blood-thinning (anticoagulant) medication
- People whom the trial investigator considers unsuitable for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8618763995357
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Remimazolam Plasma Concentration; Remimazolam PK Parameters; Remimazolam PK Parameters; Remimazolam PK Parameters; Remimazolam PK Parameters; Remimazolam PK Parameters; Remimazolam PK Parameters; Remimazolam PK Parameters; Remimazolam PK Parameters; Remimazolam PK Parameters; Remimazolam PK Parameters; CNS 7054 (Metabolite) PK Parameters; CNS 7054 (Metabolite) PK Parameters; CNS 7054 (Metabolite) PK Parameters; CNS 7054 (Metabolite) PK Parameters; CNS 7054 (Metabolite) PK Parameters; CNS 7054 (Metabolite) PK Parameters; CNS 7054 (Metabolite) PK Parameters; Sedation Depth (PD); Time to Loss of...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.